Protara Therapeutics, Inc.
TARA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,596 | -$40,420 | -$65,952 | -$47,252 |
| Dep. & Amort. | $332 | $341 | $248 | $117 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,125 | $6,092 | $6,688 | $10,362 |
| Change in WC | $4,007 | -$4,139 | $539 | $534 |
| Other Non-Cash | $324 | $569 | $32,020 | $1,737 |
| Operating Cash Flow | -$35,808 | -$37,557 | -$26,457 | -$34,502 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$63 | -$45 | -$120 | -$596 |
| Net Acquisitions | $0 | $0 | -$15 | $98 |
| Inv. Purchases | -$29,382 | -$12,186 | -$43,550 | -$124,748 |
| Inv. Sales/Matur. | $48,600 | $65,338 | $58,620 | $27,150 |
| Other Inv. Act. | $0 | $0 | $15 | -$98 |
| Investing Cash Flow | $19,155 | $53,107 | $14,950 | -$98,194 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $136,006 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$91 | -$90 | -$228 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,859 | $0 | $0 | $0 |
| Financing Cash Flow | $139,865 | -$91 | -$90 | -$228 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $123,212 | $15,459 | -$11,597 | -$132,924 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40,331 | $24,872 | $36,469 | $169,393 |
| End Cash | $163,543 | $40,331 | $24,872 | $36,469 |
| Free Cash Flow | -$35,871 | -$37,602 | -$26,577 | -$35,098 |